Comparator Study of PEG 3350 Versus Prucalopride in Females With Chronic Constipation
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Norgine
Related studies linked through entity extraction aliases.
Study to Assess the Tolerability, Safety and Efficacy of an Adapted Gut Cleansing Solution in Routine Colon Cleansing Prior to Colonoscopies
- Status
- COMPLETED
- Phase
- PHASE2
Effect of 7 Days of Dosing With a 10 mg Rectal Suppository of NRL001in Patients With Faecal Incontinence
- Status
- COMPLETED
- Phase
- PHASE1
Sensitivity of Alternative NRL972 Detection Methods in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Safety, Tolerability, Pharmacodynamic and Pharmacokinetics of a Single Rectal Application of 10 mg NRL001 in Elderly Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Safety, Tolerability, Pharmacodynamic and Pharmacokinetics of 7.5, 10, 12.5 or 15 mg NRL001 in a 2 g Suppository for 14 Days
- Status
- COMPLETED
- Phase
- PHASE1
Effect of Chronic Viral Hepatitis on the Pharmacokinetics of NRL972.
- Status
- COMPLETED
- Phase
- PHASE2
Reproducibility of Child-Turcotte-Pugh (CTP) Rating and NRL972 Pharmacokinetics in Patients With Cirrhosis
- Status
- COMPLETED
- Phase
- PHASE1
Scintigraphic Assessment Following Klean-Prep® or Moviprep®
- Status
- COMPLETED
- Phase
- PHASE1
Effect of Single Doses of 10 mg NRL001 Applied as a Suppository to the Anal Canal or Rectum
- Status
- COMPLETED
- Phase
- PHASE1
Effects of Oral PEG 3350 on Electrolyte Balance
- Status
- COMPLETED
- Phase
- PHASE1
Evaluation of the PK of NRL972 Following Pre- and co-Administration of Ursodeoxycholic Acid and Cloxacillin
- Status
- COMPLETED
- Phase
- PHASE1
Study to Investigate Safety and Response to 1 or 2 g Rectal Suppositories Containing 5 or 10 mg NRL001.
- Status
- COMPLETED
- Phase
- PHASE1
Clearance of NRL972 in Patients With Cirrhosis, Nonalcoholic Steatohepatitis (NASH) and in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Evaluation of the Pharmacokinetics of NRL972 Following Pre-Administration of Rifampicin and Cyclosporine
- Status
- COMPLETED
- Phase
- PHASE1
Clearance of NRL972 in Patients With Cirrhosis and in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Study of Escalating Doses of NRL001 Given in Slow-release Rectal Suppositories of Different Weights
- Status
- COMPLETED
- Phase
- PHASE1
Constipation Associated With Irritable Bowel Syndrome (IBS-C)
- Status
- COMPLETED
- Phase
- PHASE3
PK of NRL972 in Patients with Nonalcoholic Steatohepatitis (NASH) and Non-Alcoholic Fatty Liver Disease (NAFLD)
- Status
- COMPLETED
- Phase
- PHASE2
Multi-national Cirrhosis Study to Characterise the Association Between the Pharmacokinetics of NRL972 and Disease Severity.
- Status
- COMPLETED
- Phase
- PHASE3